Medicine Man Technologies (Medicine Man Technologies) EPS (Basic) : $-0.84 (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Medicine Man Technologies EPS (Basic)?

Medicine Man Technologies's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was $-0.24. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.84.

Medicine Man Technologies's EPS (Diluted) for the three months ended in Mar. 2024 was $-0.24. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.85.

Medicine Man Technologies's EPS without NRI for the three months ended in Mar. 2024 was $-0.23. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was -0.88.

During the past 3 years, the average EPS without NRI Growth Rate was -15.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Medicine Man Technologies's highest 3-Year average EPS without NRI Growth Rate was 3.20% per year. The lowest was -320.50% per year. And the median was -24.30% per year.

Medicine Man Technologies EPS (Basic) Historical Data

The historical data trend for Medicine Man Technologies's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicine Man Technologies EPS (Basic) Chart

Medicine Man Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-0.50

-0.47

0.17

-0.49

-0.66

Medicine Man Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial															-0.01	-0.15	-0.02	-0.43	-0.24

Medicine Man Technologies EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Medicine Man Technologies's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-34.549	-	8.155)	/	64.535
	=	-0.66

Medicine Man Technologies's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-16.053	-	2.155)	/	76.007
	=	-0.24

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.84

Medicine Man Technologies (OTCPK:SHWZ) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Medicine Man Technologies EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Medicine Man Technologies's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicine Man Technologies (Medicine Man Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicine Man Technologies Inc (OTCPK:SHWZ) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

SHWZ:Canada

Address

4880 Havana Street, Suite 201, Denver, CO, USA, 80239

Website

https://www.schwazze.com

Medicine Man Technologies Inc is engaged in providing general consulting services in the cannabis industry. The company also provide seminar which includes giving guidance and tips on industry opportunities, medical and recreational market trends, cultivation methodologies and technology, extraction technology, dispensary operation, security requirements. The company's operating segment includes- Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation and sale of both wholesale cannabis and non-cannabis products; Other, consisting of all other income and expenses. It generates maximum revenue from the Retail segment. The company is now operating under its new trade name, Schwazze.

Executives

Christine Jones	officer: Chief Legal Officer	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Forrest Hoffmaster	officer: CFO	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Nirup Krishnamurthy	director, officer: President	4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Kathy P Vrabeck	director	625 WESTPORT PARKWAY, GRAPEVINE TX 76051
Jeff Garwood	director	55 TABBY CIRCLE, DAUFUSKIE ISLAND SC 29915
Pratap Chandra Mukharji	director	4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Salim Husan Wahdan	director	4880 HAVANA ST., STE. 201, DENVER CO 80239
Paul Joseph Montalbano	director	4880 HAVANA ST., STE. 201, DENVER CO 80239
Brad Stewart	director	C/O SEMPER PARATUS ACQUISITION CORP., 767 THIRD AVENUE, 38TH FLOOR, NEW YORK NY 10017
Justin Dye	director, 10 percent owner, officer: CEO	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Jeffrey Alley Cozad	director, 10 percent owner	C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Crw Capital Holdings Ii, Llc	10 percent owner	4740 W. MOCKINGBIRD LANE, STE 195579, DALLAS TX 75209
Crw Capital, Llc	10 percent owner	4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209
Crw Capital Cann Holdings, Llc	10 percent owner	4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209
Brian Ruden	10 percent owner	C/O 4880 HAVANA STREET, SUITE 102, DENVER CO 80239